Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
CSTE · Nasdaq · United States · Cut Stone & Stone Products
In shortCaesarstone Ltd. is loss-making, burns cash and holds more cash than debt, with revenue shrinking (−10.4% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -31.6% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -34.6% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -66.9% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -59.8% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.83× | 86/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.19× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -1821.87× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 0.56 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -11.8% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 22.3% | 29/100 |
| Operating margin volatility | 13.1% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -16.8% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 644 | 691 | 565 | 443 | 397 |
| Cost of revenue | 472 | 528 | 473 | 347 | 324 |
| Gross profit | 171 | 163 | 92 | 97 | 73 |
| Research & development | 4.2 | 4.1 | 5.1 | 5 | 5.7 |
| Operating income | 27 | (59) | (88) | (42) | (126) |
| Interest expense | 2 | 0.3 | 0.4 | 0.3 | 0.1 |
| Pre-tax income | 20 | (56) | (87) | (42) | (133) |
| Income tax | 2 | 0.8 | 21 | 1.1 | 4.3 |
| Net income | 19 | (57) | (108) | (43) | (137) |
| Diluted EPS | $0.51 | −$1.66 | −$3.13 | −$1.13 | −$3.98 |
| Diluted shares (millions) | 35 | 34 | 35 | 35 | 35 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
0.56 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Mar 4, 2026